As per our report, the size of the global breast imaging market is anticipated to grow at 8.58% CAGR from 2021 to 2026. The global market was valued at USD 3.8 billion in 2021 and is forecasted to worth USD 5.74 billion by 2026.
In medicine, breast imaging is the representation or reproduction of a breast's form. There are various methods of breast imaging. Scintimammography is a type of breast imaging test that involves detecting cancer cells in the breasts of some women who have had abnormal mammograms or for those who have dense breast tissue, post-operative scar tissue, or breast implants. Still, it is not used for screening or in place of a mammogram.
MARKET DRIVERS:
Rising incidences of breast cancer across the world and growing prevalence for early diagnosis of disease are majorly propelling the growth of the global breast imaging market.
Besides, the rise in the geriatric population, increasing initiative steps by the government in spreading awareness over the treatment procedures for breast cancer in rural areas are featuring to expand the growth of the breast imaging market. Also, the rise in the focus on determining dense breast tissue with these imaging techniques is spurring the market's demand.
The emergence of the latest technological developments in the medical sector is solely to surge growth opportunities for the market. The rise in investments from both government and non-government organizations, the growing urbanized population, and the rising number of research and development institutes to introduce highly featured products are ascribed to bolster the demand of the breast imaging market. A rise in healthcare spending, increasing the constructional activities of hospitals with advanced equipment to improve diagnosis and therapeutics procedures, is straight impacting the market growth towards positive.
MARKET RESTRAINTS:
The cost of installing and maintaining the devices is a bit expensive, and this has been a major challenging factor for the market developers. The lack of skilled persons in monitoring the systems effectively is slowly restraining the demand of the breast imaging market. The rise in the complexity of real-time applications and system failures is inhibiting the growth rate of this market. Frequent changes in the technologies may also decline the demand for the breast imaging market. These devices' exposure to high radiation, where they show adverse effects on the patients, is also impeding the market's growth.
Impact of COVID-19 on the global breast imaging market:
The COVID-19 has been named a pandemic by the WHO and has affected many healthcare applications worldwide. The pandemic has impacted negatively on the breast imaging market. Many women postponed or canceled their diagnostics and examinations due to the spread of COVID 19. The activities were resumed in the last months of 2020 by taking certain precautions in the laboratories and diagnostic centres. Mammography departments among the hospitals are facing new challenges. Few centres have launched new diagnosis methods such as tele-mammography consultations. The impact of COVID-19 has got an immense effect on the breast imaging market. Few countries have cancelled breast screening and diagnosis and decided to treat the patients in emergency need of treatment.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Analysed |
By Technology and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
This research report on the global breast imaging market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2025.
Breast Imaging Market - By Technology:
Based on technology, the mammography segment accounted for a significant market share due to the technological advancements in mammography instruments. For instance, the introduction of portable and digital mammography instruments is expected to aid market growth further. The digital mammography equipment provides advantages such as reduced examination times and space requirement for data storage, consequently leading the tomography segment to witness lucrative growth compared to other imaging systems.
Breast Imaging Market - By Region:
Regionally, North America held the largest market share due to the increased expenditure in the development of futuristic technologies coupled with the rising awareness amongst patients. Asia Pacific is expected to register the highest CAGR in the coming years. Acquisitions and new product development endeavors in the growing economies of India and China are expected to boost further the growth of the breast imaging market over the forecast period.
In addition to the growth in mature markets, emerging economies such as MEA and Latin America are also expected to witness lucrative growth over the forecast period. Factors such as improvements in the healthcare infrastructure, the rising investment, and the multi-national industrial growth within this region, and the increase in the number of government initiatives to raise awareness drive the market growth in the developing areas.
KEY MARKET PARTICIPANTS:
Notable companies dominating the global breast imaging market are Hologic, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Fujifilm Holdings Corporation, Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc. and Dilon Technologies, Inc.
MAJOR HAPPENINGS IN THIS MARKET IN THE RECENT PAST:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Ionizing Technologies
5.1.2.1 Mammography
5.1.2.2 Digital Mammography
5.1.2.3 3D Mammography
5.1.2.4 Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
5.1.2.5 Positron Emission Tomography and Computed Tomography (PET-CT)
5.1.2.6 Cone-Beam Computed Tomography (CBCT)
5.1.2.7 Positron Emission Mammography (PEM)
5.1.3 Non-ionizing Technologies
5.1.3.1 Breast MRI
5.1.3.2 Breast Ultrasound
5.1.3.3 Automated Whole-Breast Ultrasound (AWBU)
5.1.3.4 Breast Thermography
5.1.3.5 Optical Imaging
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Siemens Healthcare
8.4 Philips Healthcare
8.5 Fujifilm Holdings Corporation Gamma Medica Inc.
8.6 Toshiba Corporation
8.7 Sonocine Inc.
8.8 Aurora Imaging Technolog Inc.,
8.9 Dilon Technologies, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
